Pages that link to "Q70440093"
Jump to navigation
Jump to search
The following pages link to The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin (Q70440093):
Displaying 47 items.
- Pharmacologic therapy of ventricular arrhythmias (Q34063156) (← links)
- Pharmacokinetics of drugs in patients with the nephrotic syndrome (Q34479563) (← links)
- Altered plasma albumin in the newborn infant (Q34515542) (← links)
- Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environment (Q35132895) (← links)
- Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia (Q35206770) (← links)
- A standard approach to compiling clinical pharmacokinetic data (Q36642205) (← links)
- Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease (Q37000768) (← links)
- Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II). (Q37950599) (← links)
- Drug level monitoring in paediatric practice (Q38914642) (← links)
- Drug Kinetics and Artificial Kidneys1 (Q39174913) (← links)
- Digitalis pharmacokinetics and therapy with respect to impaired renal function (Q39617121) (← links)
- Plasma protein binding of digitoxin and some other drugs in renal disease (Q39656623) (← links)
- Clinical pharmacokinetics of antiarrhythmic drugs (Q39709558) (← links)
- Effects of Renal Disease upon Drug Disposition (Q39780234) (← links)
- Drug Prescribing in Renal Failure (Q39799026) (← links)
- Clinical Pharmacokinetics of Phenytoin (Q39806205) (← links)
- Decreased serum protein binding of glymidine in icteric liver disease and its partial correction with charcoal (author's transl (Q39894132) (← links)
- Measurement of Therapeutic Agents in Blood (Q39935532) (← links)
- Effect of disease states on plasma protein binding of drugs. (Q39946887) (← links)
- Impaired Binding of Drugs and Endogenous Ligands in Renal Diseases (Q40148602) (← links)
- Clinical Pharmacokinetics of Cardiac Glycosides in Patients with Renal Dysfunction (Q40149119) (← links)
- Pharmacokinetics in Renal Failure (Q40165291) (← links)
- Disease-related alterations in cardiac glycoside disposition (Q40246640) (← links)
- Therapeutic drug monitoring of antiarrhythmic agents (Q40327652) (← links)
- Drug protein binding and the nephrotic syndrome (Q40640422) (← links)
- Plasma level monitoring of anticonvulsants (Q40640453) (← links)
- The binding of drugs to plasma proteins from patients with poor renal function (Q40640466) (← links)
- Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease (Q40897047) (← links)
- Clinical pharmacokinetics of digitoxin (Q44725057) (← links)
- Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin (Q46934558) (← links)
- Pharmacodynamics and pharmacokinetics of thiopental (Q48394666) (← links)
- Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients (Q49170312) (← links)
- Drug protein binding in chronic renal failure: Evaluation of nine drugs (Q49172453) (← links)
- Reduced in vitro binding of tryptophan by plasma in uremia (Q51675222) (← links)
- Diphenylhydantoin: Correlation between protein binding and albumin concentration (Q66960430) (← links)
- The clinical pharmacokinetics of phenytoin (Q67053866) (← links)
- Increased binding of quinidine to serum albumin and lipoproteins in anuric rats (Q67314552) (← links)
- Binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uraemic patients (Q67396592) (← links)
- Influence of acute renal failure on the protein binding of drugs in animals and in man (Q67541151) (← links)
- Lack of relationship between serum free fatty acids and impaired plasma protein binding of diphenylhydantoin in chronic renal failure (Q68210368) (← links)
- Influence of disease on binding of drugs to plasma proteins (Q69035369) (← links)
- The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin (Q69035378) (← links)
- Protein binding of piretanide in normal and uraemic serum (Q70272379) (← links)
- Endogenous ligand(s) decrease drug--protein binding in uremic sera: a fluorescence probe study (Q71246061) (← links)
- Alteration of drug-protein binding in renal disease (Q71295379) (← links)
- Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis (Q71474748) (← links)
- Plasma protein binding of frusemide in renal failure rabbits: investigation of endogenous protein binding inhibitors (Q72592918) (← links)